The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Developing and Validating Web-Based Clinical Assessments for, 2008Online Motor and Cognitive Analysis System
Objective/Rationale:
Despite advances in treatment approaches to Parkinson’s disease over the past 20 years, patient assessment methods have advanced little during this same period. Therefore, a... -
Research Grant, 2020GBA Variations, Cholinergic Degeneration, and Cognitive Decline in Parkinson’s Disease
Study Rationale:
Mutations in the GBA gene are the most common genetic risk factors for Parkinson’s disease. People with GBA mutations (GBA-PD) may develop the disease at a younger age and may have... -
Research Grant, 2011Comparing Cognitive Scales in the MUSTARDD-PD Study
Objective/Rationale:
Some people with Parkinson’s may develop dementia during their disease course. Being able to detect problems with mental function at an early stage, to monitor and to reliably... -
MJFF Research Grant, 2012Neuroimaging Markers Predict Cognitive Decline in PD
Promising Outcomes of Original Grant:
Excessive amounts of amyloid in brain tissue are believed to be toxic and cause the neuronal damage that results in dementia. Amyloid deposits can be detected in... -
Research Grant, 2022Cognitive Assessment of Non-Human Primate Models of Parkinson's Disease
Study Rationale: Cognitive impairments cause significant disability for people with Parkinson’s disease (PD). Problems such as reduced attention or difficulty following plans can occur very early in...
-
Research Grant, 2012Phase I-B Clinical Trial of AVE8112 for Cognitive Impairment in Parkinson’s Disease
Objective/Rationale:
Cognitive impairment is a symptom seen in Parkinson’s disease (PD) patients, and some can progress to dementia. AVE8112 is a PDE4 inhibitor that was in development by the...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.